ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,728.80
0.41%
US Tech 100
19,528.00
0.90%
Dow Jones
42,052.19
0.69%
Brent Oil
72.905
0.00%
Bitcoin
68,459.44
-1.23%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Wave Life Sciences Ltd (WVE) Quote

Wave Life Sciences Ltd

Wave Life Sciences Ltd (WVE)

NASDAQ
13.83
0.12
(0.88%)
Closed November 03 4:00PM
Delayed by 15 minutes
13.83
-0.01
(-0.07%)
After Hours: 7:09PM
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
13.83
Bid
6.94
Ask
14.10
Volume
642,063
13.61 Day's Range 14.05
3.50 52 Week Range 15.9199
Market Cap
1.725B
Previous Close
13.71
Open
13.86
Last Trade
50
@
13.7096
Last Trade Time
Financial Volume
$ 8,879,596
VWAP
13.8298
Average Volume (3m)
1,730,586
Shares Outstanding
124,737,862
Dividend Yield
-
PE Ratio
-30.02
Earnings Per Share (EPS)
-0.46
Revenue
115.18M
Net Profit
-57.51M

About Wave Life Sciences Ltd

WAVE Life Sciences Ltd is a preclinical biopharmaceutical company based in Singapore. It owns a diverse pipeline of nucleic acid therapeutics meant to address rare genetic diseases related to the central nervous system, muscles, eyes, liver, and skin. Its nucleic acid therapeutics target genetic def... WAVE Life Sciences Ltd is a preclinical biopharmaceutical company based in Singapore. It owns a diverse pipeline of nucleic acid therapeutics meant to address rare genetic diseases related to the central nervous system, muscles, eyes, liver, and skin. Its nucleic acid therapeutics target genetic defects to either reduce the expression of disease-promoting proteins or transform the production of dysfunctional mutant proteins into the production of functional proteins. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.wavelifesciences.com
Headquarters
Singapore, Sgp
Founded
-
Wave Life Sciences Ltd is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker WVE. The last closing price for Wave Life Sciences was $13.71. Over the last year, Wave Life Sciences shares have traded in a share price range of $ 3.50 to $ 15.9199.

Wave Life Sciences currently has 124,737,862 shares outstanding. The market capitalization of Wave Life Sciences is $1.71 billion. Wave Life Sciences has a price to earnings ratio (PE ratio) of -30.02.

Ask ADVFN Intelligence (AI)

WVE Latest News

More News

Form 8-K - Current report

October 30 2024
Edgar (US Regulatory)

Wave Life Sciences Highlights Growing Pipeline at Research Day, including INHBE siRNA Program for Obesity and New RNA Editing Programs

WVE-007 (INHBE GalNAc-siRNA for obesity) is on track to initiate a clinical trial in 1Q 2025; new preclinical data for WVE-007 demonstrate opportunities for monotherapy, for synergistic use with...

October 30 2024
GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities

October 18 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

October 18 2024
Edgar (US Regulatory)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

October 18 2024
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

October 16 2024
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

October 16 2024
Edgar (US Regulatory)

Form 8-K - Current report

October 16 2024
Edgar (US Regulatory)

Wave Life Sciences Announces First-Ever Therapeutic RNA Editing in Humans Achieved in RestorAATion-2 Trial of WVE-006 in Alpha-1 Antitrypsin Deficiency

Achieved proof-of-mechanism for Wave’s RNA editing platform; restoring levels of wild-type (edited) M-AAT that are consistent with the heterozygous “MZ” genotype with low risk of AATD lung and...

October 16 2024
GlobeNewswire Inc.

Wave Life Sciences Announces Upcoming Virtual Research Day on Wednesday, October 30, 2024

CAMBRIDGE, Mass., Oct. 16, 2024 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to...

October 16 2024
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-1.2-7.9840319361315.0315.6213.441135888714.40642748CS
45.2761.56542056078.5615.91997.85217237813.77255275CS
128.08140.521739135.7515.91995.04173058610.21861099CS
268.88179.3939393944.9515.91994.2512638218.55373072CS
528.42155.6377079485.4115.91993.510327057.29121228CS
1569.26202.6258205694.5715.91991.166305855.71636974CS
260-12.11-46.684656900525.9439.991.166693487.28852977CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
VSTEVast Renewable Ltd
$ 4.98
(149.00%)
68.54M
INVZWInnoviz Technologies Ltd
$ 0.096
(96.71%)
22.71k
CDXCChromaDex Corporation
$ 5.87
(68.19%)
37.88M
ATHAAthira Pharma Inc
$ 0.606
(41.56%)
239.63M
TILEInterface Inc
$ 23.24
(33.03%)
2.16M
EPIXESSA Pharma Inc
$ 1.45
(-72.12%)
34.3M
ELABElevai Labs Inc
$ 0.0288
(-51.19%)
202.28M
OSTOstin Technology Group Company Ltd
$ 0.275
(-45.00%)
2.27M
LXRXLexicon Pharmaceuticals Inc
$ 1.23
(-36.92%)
21M
VCIGVCI Global Ltd
$ 0.0583
(-27.58%)
26.57M
ATHAAthira Pharma Inc
$ 0.606
(41.56%)
239.63M
SQQQProShares UltraPro Short QQQ
$ 7.44
(-2.11%)
216.16M
NVDANVIDIA Corporation
$ 135.40
(1.99%)
209.27M
ELABElevai Labs Inc
$ 0.0288
(-51.19%)
202.28M
INTCIntel Corporation
$ 23.20
(7.81%)
173.47M

WVE Discussion

View Posts
TechandBio TechandBio 2 days ago
RNAI stocks are going to be the biggest driver in biotech in the through 2030 WAVE and PRQR
These could be the next ALNY
450 drugs in the pipeline worldwide for RNAI drugs.

$WVE
👍️0
boston127 boston127 2 weeks ago
Gotta love their business.

If their RNA model works, it could have fantastic results for humanity.
👍️0
PonkenPlonken PonkenPlonken 3 weeks ago
Finally,,,,,,,, "they" will water them all and things will get going. RNA in genetic diseases....
👍️0
PonkenPlonken PonkenPlonken 3 weeks ago
beautiful....
👍️0
Awl416 Awl416 3 weeks ago
Wave Life Sciences Announces First-Ever Therapeutic RNA Editing in Humans Achieved in RestorAATion-2 Trial of WVE-006 in Alpha-1 Antitrypsin Deficiency
👍️0
TechandBio TechandBio 1 month ago
WVE Can't wait for the Phase 1 Obesity indication to commence later this year or early 2025 thats the icing on the cake.

$WVE
👍️0
PonkenPlonken PonkenPlonken 1 month ago
can you say breakout?
👍️0
PonkenPlonken PonkenPlonken 1 month ago
why claim this afterwards? Pointless
👍️0
TechandBio TechandBio 1 month ago
Poetry in Motion!

$WVE
👍️0
TechandBio TechandBio 1 month ago
Solid looking for more!

Glad I doubled up last week!

$WVE
👍️0
PonkenPlonken PonkenPlonken 1 month ago
wowser there it is

Dystrophin results from a pre-specified analysis of ambulatory boys showed:
Mean absolute muscle content-adjusted dystrophin expression was 9.0% (range: 4.6-13.9%) and mean absolute unadjusted dystrophin expression was 5.5% of normal (range: 3.3-8.3%), as measured by Western Blot.
[...]
89% of ambulatory participants achieved muscle content-adjusted dystrophin levels of at least 5%.
👍️ 1
Monksdream Monksdream 2 months ago
WVE under $7
👍️0
Monksdream Monksdream 4 months ago
WVE under $10
👍️0
PonkenPlonken PonkenPlonken 4 months ago
one of the singaporean companies that does not look like a scam but rather like singaporean excellence.
👍️0
Monksdream Monksdream 6 months ago
WVE under $10
👍️0
Monksdream Monksdream 8 months ago
WVE new 52 week high
👍️0
TrendTrade2016 TrendTrade2016 8 months ago
WVE...BEAUTIFUL WEEKLY
👍️0
TrendTrade2016 TrendTrade2016 8 months ago
WVE...BIO MONSTER SETTING UP
👍️0
PRIVATE SHAREHOLDER PRIVATE SHAREHOLDER 2 years ago
Big clinical news coming shortly
👍️0
PRIVATE SHAREHOLDER PRIVATE SHAREHOLDER 2 years ago
Company reporting big news next week. Stay tuned!
👍️0
MiamiGent MiamiGent 2 years ago
WVE stretched out this morning!

WAVE LIFE SCIENCES LTD
$5.24 +$0.20 (+3.97%)

WVE is a real stock!

https://stockcharts.com/h-sc/ui?s=WVE
👍️0

Your Recent History

NASDAQ
WVE
Wave Life Sciences
FX
HKDSGD
HKD vs SGD
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved